Showing 1,075 results

Filters Content type: News, Editors' picks Country: Zimbabwe
Cancer

Lengthening dosing schedule of HPV vaccine may provide effective option for expanding use of vaccine

Editor's pick
Eurekalert Medicine & Health
12 April 2011
TB treatment

Use of combination drug regimen for treating TB may represent an effective treatment option

Editor's pick
Eurekalert Medicine & Health
12 April 2011

Trust gay blood donors to tell the truth about safe sex

Editor's pick
The Guardian
11 April 2011
Finance & funding

Zimbabwe: No money for new drugs

Editor's pick
The Zimbabwean
9 April 2011
Improving HIV care

Zimbabwe: Aids Council to Unveil ARV Electronic Card System

Editor's pick
AllAfrica
8 April 2011
Religion & faith

Report says people with HIV/Aids need more than prayers

Editor's pick
Independent Catholic News
4 April 2011
New & experimental hepatitis C treatment

Bristol-Myers Interferon-Free Combo Cured Hepatitis Patients

Editor's pick
Bloomberg
4 April 2011
New & experimental hepatitis C treatment

Idera Pharmaceuticals Presents Data from a Phase 1 Clinical Trial of IMO-2125 in Treatment-Naïve Genotype 1 HCV Patients at EASL 2011

Editor's pick
Business Wire
4 April 2011
Cardiovascular disease

Vitamin D levels linked with health of blood vessels

Editor's pick
Eurekalert Medicine & Health
3 April 2011
New & experimental hepatitis C treatment

Inhibitex Reports Positive Safety and Antiviral Data from Its Phase 1b Study of HCV Nucleotide Inhibitor INX-189

Editor's pick
Pipeline Review
1 April 2011
New & experimental hepatitis C treatment

'Fantastic' data on Novartis' first-in-class hep C antiviral

Editor's pick
Pharma Times
1 April 2011
New & experimental hepatitis C treatment

Well-known statin could be recycled as HCV therapy supplement

Editor's pick
EASL
1 April 2011
New & experimental HIV treatments

AIDS Virus Blocked From Entering Cells By Engineered Protein Fragment

Editor's pick
HIV / AIDS News From Medical News Today
1 April 2011
New & experimental hepatitis C treatment

Results From Phase 3 REALIZE Study Showed Telaprevir-Based Therapy Significantly Improved SVR (Viral Cure) Rates in People Whose Prior Treatment For Hepatitis C Was Unsuccessful

Editor's pick
Business Wire
31 March 2011
PrEP

PrEP: A Possible Approval Like No Other

Editor's pick
Poz
31 March 2011
Finance & funding

US Republicans move to block abortion services in poor countries

Editor's pick
The Guardian
31 March 2011
New & experimental hepatitis C treatment

Interim Phase 2 Data Showed Rapid Viral Response to VX-222 in Combination with Telaprevir, Pegylated-Interferon and Ribavirin Among People With Hepatitis C

Editor's pick
Business Wire
31 March 2011
Types of HIV tests

5 need to knows about home self-test health kits

Editor's pick
Which?
31 March 2011
New & experimental HIV treatments

What Lies Ahead: An Activist's View of Promising HIV Treatment Research

Editor's pick
The Body
31 March 2011
Epidemiology

UN Secretary-General outlines new recommendations to reach 2015 goals for AIDS response

Editor's pick
UNAIDS
31 March 2011
Pharmaceutical industry

U.S. jury rejects Glaxo antitrust claims vs Abbott

Editor's pick
Reuters
31 March 2011
Hepatitis & HIV

UCLA study finds cholesterol regulator plays key role in development of liver scarring, cirrhosis

Editor's pick
Eurekalert Medicine & Health
30 March 2011
New & experimental hepatitis C treatment

Pharmasset Initiates Phase 2b ATOMIC Trial of PSI-7977 for Multiple HCV Genotypes

Editor's pick
PR Newswire
30 March 2011
Hepatitis C treatment

Presidio Pharmaceuticals, Inc. Announces Positive Results in a Phase 1b Clinical Trial of PPI-461, a Novel, Potent Broadly-Active Hepatitis C Virus (HCV) Inhibitor

Editor's pick
Business Wire
30 March 2011